|
NCOA5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.548000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.924400E-03 |
| Normal-vs-Stage2 |
8.677400E-01 |
| Normal-vs-Stage3 |
7.736000E-01 |
| Normal-vs-Stage4 |
9.932200E-01 |
| Stage1-vs-Stage2 |
3.799600E-02 |
| Stage1-vs-Stage3 |
5.282200E-03 |
| Stage1-vs-Stage4 |
6.415100E-03 |
| Stage2-vs-Stage3 |
9.620000E-01 |
| Stage2-vs-Stage4 |
8.717200E-01 |
| Stage3-vs-Stage4 |
7.934600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.164580E-01 |
| Normal-vs-AfricanAmerican |
2.504400E-01 |
| Normal-vs-Asian |
2.103400E-03 |
| Caucasian-vs-AfricanAmerican |
7.563400E-01 |
| Caucasian-vs-Asian |
3.625900E-02 |
| AfricanAmerican-vs-Asian |
1.186970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.652600E-01 |
| Normal-vs-Female |
7.364300E-03 |
| Male-vs-Female |
3.688300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.935600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.344100E-02 |
| Normal-vs-Age(61-80Yrs) |
9.799900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.028800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.493800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.995000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.984200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.539400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.955600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.209430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.525510E-02 |
| Normal-vs-Grade 2 |
1.003050E-03 |
| Normal-vs-Grade 3 |
7.241000E-01 |
| Normal-vs-Grade 4 |
3.761800E-01 |
| Grade 1-vs-Grade 2 |
4.833600E-02 |
| Grade 1-vs-Grade 3 |
5.359400E-04 |
| Grade 1-vs-Grade 4 |
1.791110E-04 |
| Grade 2-vs-Grade 3 |
4.169600E-04 |
| Grade 2-vs-Grade 4 |
2.027700E-04 |
| Grade 3-vs-Grade 4 |
1.806990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.402900E-04 |
| Normal-vs-ccB subtype |
9.577000E-01 |
| ccA subtype-vs-ccB subtype |
4.35109999999961E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.986630E-01 |
| Normal-vs-N1 |
7.264800E-01 |
| N0-vs-N1 |
3.939400E-01 |
|
|
